INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ)
$30.9 0.36 (1.1788%)
Analysed INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) News Sources
SNY & REGN's Dupixent Gets EU Approval for Pediatric Use in Urticaria
13-04-2026
yahoo.com
Has The Strong Three-Year Run Left Indivior Pharmaceuticals (INDV) Priced Too Richly Today?
13-04-2026
yahoo.com
IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results
10-04-2026
yahoo.com
KYMR Set to Earn Milestone Payment as GILD Secures License for KT-200
10-04-2026
yahoo.com
How Much Upside is Left in Indivior Pharmaceuticals Inc. (INDV)? Wall Street Analysts Think 45.99%
10-04-2026
yahoo.com
ACIU Stock Rallies 16.3% in a Week: Here's What You Need to Know
09-04-2026
yahoo.com
Indivior to Report First Quarter 2026 Financial Results and Host Webcast on April 30th
09-04-2026
yahoo.com
Soleno Therapeutics Stock Rallies 56.4% in a Week: Here's Why
08-04-2026
yahoo.com
SNY's Lunsekimig Succeeds in Asthma & CRSwNP Studies, Fails in Eczema
07-04-2026
yahoo.com
IMVT Stock Falls 2.4% as Batoclimab Misses Late-Stage Study Endpoints
06-04-2026
yahoo.com
What is the current price of INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ)?
The current price of INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) is $30.9.
INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) absolute price change since previous trading day?
The absolute price change of INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) since the previous trading day is $0.36.
INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) percentage price change since previous trading day?
The percentage price change of INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) since the previous trading day is 1.1788%.
What is the most recent average sentiment score for INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ)?
The most recent average sentiment score for INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) is 65 out of 100.
What is the most recent average sentiment for INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ)?
The most recent sentiment for INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) is .
SEC-8K** Filing Available For INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.